CTA Regulatory Guidelines and Compliance 3

Question 1

Under ICH E6(R2), which party is primarily responsible for implementing and maintaining a quality management system for clinical trials?

Accepted Answer

The sponsor

Answer

ICH E6(R2) places primary responsibility on the sponsor to implement and maintain a quality management system proportionate to the risks inherent in the trial.

Question 2

What is the purpose of a Clinical Study Report (CSR) as defined by ICH E3?

Accepted Answer

To provide an integrated report of the trial's methods, results, and conclusions

Answer

ICH E3 defines the CSR as a comprehensive document integrating study methods, clinical results, and statistical analyses to support regulatory submissions.

Question 3

Which FDA regulation requires that electronic records and electronic signatures used in regulated activities be trustworthy, reliable, and equivalent to paper records?

Accepted Answer

21 CFR Part 11

Answer

21 CFR Part 11 establishes criteria under which FDA considers electronic records and electronic signatures to be trustworthy and equivalent to traditional paper-based records.

Question 4

An investigator delegates a task to an unqualified study coordinator without documenting the delegation. Which GCP principle is violated?

Accepted Answer

Delegation of authority

Answer

Delegation of authority requires that all delegated tasks be assigned only to qualified personnel and documented on a delegation log, per ICH E6(R2).

Question 5

Under 21 CFR Part 50, which population requires additional safeguards when obtaining informed consent?

Accepted Answer

Vulnerable subjects such as children and prisoners

Answer

21 CFR Part 50 Subpart D requires additional IRB-approved protections for vulnerable populations including children, prisoners, and economically or educationally disadvantaged persons.

(CTA) Clinical Trial Associate Certification Practice Test

(CTA) Clinical Trial Associate Certification Practice Test

CTA Regulatory Guidelines and Compliance 3